Technical Analysis for COR - Cencora, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 239.76 | 0.76% | 1.81 |
COR closed up 0.76 percent on Thursday, April 25, 2024, on 73 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Earnings due: Apr 30
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Crossed Above 50 DMA | Bullish | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| 50 DMA Resistance | Bearish | 0.76% | |
| Outside Day | Range Expansion | 0.76% | |
| 50 DMA Resistance | Bearish | 0.87% | |
| NR7 | Range Contraction | 0.87% | |
| Inside Day | Range Contraction | 0.87% | |
| Fell Below 50 DMA | Bearish | 1.23% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 13 hours ago |
| Up 1% | about 14 hours ago |
| 20 DMA Resistance | about 16 hours ago |
| Rose Above 20 DMA | about 16 hours ago |
| Rose Above Previous Day's High | about 16 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/30/2024
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $200 billion in annual revenue.
Sector: Healthcare
Industry: Medical Distribution
Keywords: Pharmaceutical Healthcare Products
Classification
Sector: Healthcare
Industry: Medical Distribution
Keywords: Pharmaceutical Healthcare Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 246.75 |
| 52 Week Low | 162.1724 |
| Average Volume | 1,137,182 |
| 200-Day Moving Average | 206.17 |
| 50-Day Moving Average | 238.17 |
| 20-Day Moving Average | 239.31 |
| 10-Day Moving Average | 237.38 |
| Average True Range | 3.28 |
| RSI (14) | 53.49 |
| ADX | 20.3 |
| +DI | 17.25 |
| -DI | 20.41 |
| Chandelier Exit (Long, 3 ATRs) | 236.90 |
| Chandelier Exit (Short, 3 ATRs) | 242.94 |
| Upper Bollinger Bands | 245.55 |
| Lower Bollinger Band | 233.08 |
| Percent B (%b) | 0.54 |
| BandWidth | 5.21 |
| MACD Line | -0.11 |
| MACD Signal Line | 0.06 |
| MACD Histogram | -0.1651 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 243.96 | ||||
| Resistance 3 (R3) | 243.92 | 242.49 | 243.26 | ||
| Resistance 2 (R2) | 242.49 | 241.42 | 242.51 | 243.03 | |
| Resistance 1 (R1) | 241.12 | 240.76 | 241.81 | 241.16 | 242.79 |
| Pivot Point | 239.69 | 239.69 | 240.03 | 239.71 | 239.69 |
| Support 1 (S1) | 238.32 | 238.62 | 239.01 | 238.36 | 236.73 |
| Support 2 (S2) | 236.89 | 237.96 | 236.91 | 236.49 | |
| Support 3 (S3) | 235.52 | 236.89 | 236.26 | ||
| Support 4 (S4) | 235.56 |
